Case Report: Hemiparkinsonism in a Patient With Multiple Sclerosis
In this case, there was a causal relationship between comorbid diseases.
Andrea P. Lee, MD; Giulietta M. Riboldi, MD; Ilya Kister, MD; Jonathan E. Howard, MD; and Ritesh A. Ramdhani, MD
Multiple Sclerosis Minute: Telemedicine and Multiple Sclerosis
Telemedicine is acceptable to patients and clinicians in the continuum of clinic-to-in-home care and reduces barriers to care.
Valerie J. Block, DPTSc, PT; and Riley Bove, MD, MMSc
Guest Medical Editor's Page
The Importance of Sleep
Sleep has a critical role in brain health and is an essential part of improving neurologic care for all of our patients.
Logan Schneider, MD
Dizziness and Vertigo
Part 1: Untangling the complexity of dizziness and vertigo requires a careful history.
Daniel R. Gold, DO; and Ari A. Shemesh, MD
Emerging Therapies for Progressive Multiple Sclerosis
A number of agents with putative neuroprotective effects have shown promise in recent clinical trials.
Matthew Tremblay, MD, PhD
Physical therapy, exercise, physical activity, and medications adapted to individual needs can all help maintain the ability to walk.
Michelle H. Cameron, MD, PT, MCR; and Ylva E. Nilsagård, PT, PhD
Neuromyelitis Optica Spectrum Disorders
It is critical to maintain a high index of suspicion for these conditions when evaluating a patient with demyelination to avoid delays in treatment.
Michael J. Bradshaw, MD; and Dorlan Kimbrough, MD
Pediatric-Onset Multiple Sclerosis
Information from clinical trials in children with MS is furthering understanding and improving treatment options for this rare presentation.
Brenda L. Banwell, MD; and Duriel I. Hardy, MD
Immunopathogenesis of Multiple Sclerosis
Disruption of immune tolerance, inflammation, and blood-brain–barrier breach lead to demyelination and axonal injury.
Neeta Garg, MD; Ye Hu, MD; and Kottil W. Rammohan, MD
POINT-COUNTERPOINT: Natalizumab Extended-Interval Dosing
Optimism vs caution for using extended-interval dosing to prevent progressive multifocal leukoencephalopathy.
David B. Clifford, MD; and John F. Foley, MD
Cover Focus: Multiple Sclerosis & Demyelinating Disorders
Multiple Sclerosis Misdiagnosis
Accurate diagnosis requires correspondence to typical clinical syndromes, correct interpretation of radiologic and CSF data, and thorough evaluation for mimics.
Alexandra Galati, MD; and Marwa Kaisey, MD
Guest Medical Editor's Page
A Coming of Age for Neuroimmunology
Increasingly complex diagnostics and highly effective disease-modifying therapy come with challenges in clinical decision making.
Aaron M. Carlson, MD
MS Minute: Introducing The New Editors
Our new editors continue their professional collaboration to help advance care of patients with MS.
Barbara S. Giesser, MD, FAAN, FANA; and Lawrence Samkoff, MD, FAAN
The return of the great imitator makes it critical to know the guidelines for testing for neurosyphilis.
Nabil Ali, MD; and Veronica Hocker, MD
Spotlight Topic: Neuropsychiatry
Cognitive Complaints and Neuropsychologic Testing
When should neuropsychologic tests be ordered and what questions should testing answer?
Nabil Ali, MD; Laura M. Clark, PhD, ABPP; and Kendra Corning, PsyD, HSPP
Case Report: Longitudinally Extensive Transverse Myelitis
The borderline of neuromyelitis optica and systemic lupus erythematosus.
Ylec Mariana Cardenas, MD; Lakshmi Leishangthem, MD; Aparna Prabhu, MD; David Roby, MD; Pooja SirDeshpande, MD; and Saman Zafar, MD
MS Minute: Late-Breaking Data From ECTRIMS—Evobrutinib Safety and Efficacy
A potential new first-in-class treatment affects Bruton's tyrosine kinase.
Daniel Kantor, MD, FAAN, FANA
Healthy Cognitive Aging
There are evidence-based tools for staying sharp throughout the lifespan.
Brian K. Lebowitz, PhD, ABPP-CN; Elizabeth Londen, PhD; and Thomas Preston, PhD, ABPP-CN
Cover Focus: Technology & Wellness
Treating Stress to Improve Neurologic Outcomes
Research on the interaction between hormones and seizures supports the importance of helping patients manage stress.
Riley Bove, MD, MMSc; and Graham R. Huesmann, MD, PhD